P3 Health Partners Stock Return On Asset
| PIII Stock | USD 0.25 0.01 4.17% |
P3 Health Partners fundamentals help investors to digest information that contributes to P3 Health's financial success or failures. It also enables traders to predict the movement of PIII Stock. The fundamental analysis module provides a way to measure P3 Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to P3 Health stock.
The current Return On Assets is estimated to decrease to -0.07. PIII | Return On Asset |
P3 Health Partners Company Return On Asset Analysis
P3 Health's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current P3 Health Return On Asset | -0.12 |
Most of P3 Health's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, P3 Health Partners is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
PIII Return On Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for P3 Health is extremely important. It helps to project a fair market value of PIII Stock properly, considering its historical fundamentals such as Return On Asset. Since P3 Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of P3 Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of P3 Health's interrelated accounts and indicators.
Click cells to compare fundamentals
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
PIII Total Assets
Total Assets |
|
Based on the latest financial disclosure, P3 Health Partners has a Return On Asset of -0.1202. This is 98.63% lower than that of the Health Care Equipment & Supplies sector and significantly lower than that of the Health Care industry. The return on asset for all United States stocks is 14.14% lower than that of the firm.
PIII Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses P3 Health's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of P3 Health could also be used in its relative valuation, which is a method of valuing P3 Health by comparing valuation metrics of similar companies.P3 Health is currently under evaluation in return on asset category among its peers.
PIII Fundamentals
| Return On Equity | -0.41 | ||||
| Return On Asset | -0.12 | ||||
| Profit Margin | (0.05) % | ||||
| Operating Margin | (0.08) % | ||||
| Current Valuation | 122.33 M | ||||
| Shares Outstanding | 162.86 M | ||||
| Shares Owned By Insiders | 23.20 % | ||||
| Shares Owned By Institutions | 24.98 % | ||||
| Number Of Shares Shorted | 1.02 M | ||||
| Price To Book | 0.34 X | ||||
| Price To Sales | 0.09 X | ||||
| Revenue | 1.27 B | ||||
| Gross Profit | (7.75 M) | ||||
| EBITDA | (81.07 M) | ||||
| Net Income | (57.77 M) | ||||
| Cash And Equivalents | 63.15 M | ||||
| Cash Per Share | 1.52 X | ||||
| Total Debt | 121.94 M | ||||
| Debt To Equity | 0.08 % | ||||
| Current Ratio | 0.75 X | ||||
| Book Value Per Share | 1.22 X | ||||
| Cash Flow From Operations | (76.03 M) | ||||
| Short Ratio | 1.21 X | ||||
| Earnings Per Share | (0.86) X | ||||
| Target Price | 0.63 | ||||
| Number Of Employees | 400 | ||||
| Beta | 1.14 | ||||
| Market Capitalization | 131.24 M | ||||
| Total Asset | 860.97 M | ||||
| Retained Earnings | (367.34 M) | ||||
| Working Capital | (133.35 M) | ||||
| Net Asset | 860.97 M |
About P3 Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze P3 Health Partners's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of P3 Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of P3 Health Partners based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether P3 Health Partners is a strong investment it is important to analyze P3 Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact P3 Health's future performance. For an informed investment choice regarding PIII Stock, refer to the following important reports:Check out P3 Health Piotroski F Score and P3 Health Altman Z Score analysis. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of P3 Health. If investors know PIII will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about P3 Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.86) | Revenue Per Share 11.552 | Quarterly Revenue Growth 0.152 | Return On Assets (0.12) | Return On Equity (0.41) |
The market value of P3 Health Partners is measured differently than its book value, which is the value of PIII that is recorded on the company's balance sheet. Investors also form their own opinion of P3 Health's value that differs from its market value or its book value, called intrinsic value, which is P3 Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because P3 Health's market value can be influenced by many factors that don't directly affect P3 Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between P3 Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if P3 Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, P3 Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.